Newshot

Neuralink co-founder Max Hodak's Science Corp, which offers a retinal implant for age-related macular degeneration, raised $400M at a $3.5B valuation (Ike Swetlitz/Bloomberg)

Summary

Ike Swetlitz / Bloomberg : Neuralink co-founder Max Hodak's Science Corp, which offers a retinal implant for age-related macular degeneration, raised $400M at a $3.5B valuation — Science Corp, the company behind a retinal chip that restores some vision to people with an age-related form of blindness, is valued at $3.5 billion after a recent fundraising round.

Original text(via Techmeme)

Sponsor Posts

Featured Podcasts

Only about 687 characters could be extracted — the rest did not come through (common on sites that need scrolling or a login). Read the original for the full piece.

Published by Techmeme
This site only summarises and aggregates; copyright stays with the original author. Headlines and summaries follow the source — where they differ, the original wins.
Read the original ↗